奧聯電子(300585.SZ):劉軍勝及其一致行動人已減持11.11萬股
格隆匯9月15日丨奧聯電子(300585.SZ)公佈,公司於2021年9月15日收到持股5%以上股東劉軍勝及其一致行動人劉愛羣出具的《關於減持公司股份及被動稀釋致股份變動比例合計超過1%的吿知函》,自2021年9月3日至2021年9月15日,持股5%以上股東劉軍勝及其一致行動人劉愛羣通過深圳證券交易所以集中競價交易方式共計減持股份11.11萬股。由於公司向特定對象發行股票事項,公司總股本由160,000,000股增加至171,111,111股,導致劉軍勝及其一致行動人劉愛羣持股比例被稀釋。劉軍勝及其一致行動人劉愛羣於上述期間因股份減持及被動稀釋引起的股份變動合計比例累計已經超過1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.